Theme: Treatment and Management strategies to eradicate Hepatitis and Liver diseases

Hepatitis 2016

Hepatitis 2016

The liver supports almost every organ in the body and is vital for survival. Because of its strategic location and multidimensional functions, the liver is also prone to many diseases. Hepatitis is a common condition of inflammation of the liver. The most usual cause of this is viral, and the most common of these infections are hepatitis A, B, C, D, and E. Infection with hepatitis B virus or hepatitis C virus is the main cause of liver cancer. Other disorders caused by excessive alcohol consumption are grouped under alcoholic liver diseases and these include alcoholic hepatitis, fatty liver, and cirrhosis. Liver damage can also be caused by drugs, particularly paracetomol and drugs used to treat cancer.

Track 1: Genetic and Metabolic Liver Diseases

There are many inherited metabolic and genetic disorders that may have a pathologic impact on the liver. Haemochromatosis, Gilbert syndrome and Wilson’s disease are genetic disorders caused by accumulation of iron, bilirubin and copper in the liver. Alpha1-antitrypsin (α1-AT) deficiency is a disorder in which the normal processing of a liver-produced protein is disturbed within the liver cell.

Related Hepatitis Conferences | Liver Conferences | Conference Series LLC: 2nd International Conference on Hepatology, May 09-11, 2016 Chicago, USA; 6th Global Gastroenterologists Meeting, August 11-12, 2016 Birmingham, UK; 7th Gastroenterology and Gastroenterologists Annual Meeting, September 12-14, 2016 Atlanta, USA; 8th International Conference on Clinical Gastroenterology & Hepatology September 29-October 1, 2016 Toronto, Canada; 3rd World Congress on Hepatitis and Liver Diseases, October 10-12, 2016 Dubai, UAE; International Conference on Pancreatic Disorders and Treatment, October 17-19, 2016 Chicago, USA; European Gastroenterology Conference, October 24-25, 2016 Valencia, Spain; International Conference on Endoscopy, November 17-18, 2016 Atlanta, USA; International Conference on Digestive Diseases, December 08-09, 2016 Dubai, UAE; Digestive Disease Week, May 21-24, 2016 San Diego, USA; International Course on Gastroenterology Trujillo 2016, June 30, 2016 - July 2, 2016 Peru; Pan American Digestive Disease Week, September 10-13, 2016 Columbia; 24th Annual Meeting of the Croatian Society of Gastroenterology, September 15-18, 2016 Croatia; XXII Russian Gastroenterological Week, October 03-05, 2016, Moscow, Russia; XXV Peruvian Congress of Digestive Diseases, October 05-08, 2016 Lima, Peru; Asian Pacific Digestive Week, November 02-05, 2016 Kobe, Japan; Japan Digestive Disease Week, November 03-06, 2016 Kobe, Japan; Seoul International Digestive Disease Symposium, November 24-25, 2016 South Korea; 57th Annual Conference of Indian Society of Gastroenterology, December 15-18, 2016 New Delhi, India; American Association for the Study of Liver DiseasesAmerican Hepato-Pancreato-Biliary AssociationAmerican Liver FoundationEuropean Association for the Study of the LiverAsian Pacific Association for the Study of the LiverInternational Association for the Study of the LiverBritish Association for the Study of the LiverCanadian Association for the Study of the LiverCanadian Liver FoundationChildren's Liver Disease FoundationEuroliver FoundationHepatitis B FoundationHepatitis Foundation InternationalInternational Liver Transplantation SocietyInternational Hepato Pancreato Biliary Association

Track 2: Hepatitis Care and Cure

Treatment of Hepatitis is on the cutting edge of medicine. Hepatitis B virus infection (HBV) has been recognized as a major health problem worldwide and Hepatitis C virus (HCV) infection is the most common chronic blood borne infection in the United States. Viral hepatitis treatment depends on how active the virus is in your body. Viral hepatitis is the most common cause of hepatitis worldwide. Other causes of non-viral hepatitis include alcoholic hepatitis and autoimmune hepatitis.

Related Hepatitis Conferences | Liver Conferences | Conference Series LLC: 2nd International Conference on Hepatology, May 09-11, 2016 Chicago, USA; 6th Global Gastroenterologists Meeting, August 11-12, 2016 Birmingham, UK; 7th Gastroenterology and Gastroenterologists Annual Meeting, September 12-14, 2016 Atlanta, USA; 8th International Conference on Clinical Gastroenterology & Hepatology September 29-October 1, 2016 Toronto, Canada; 3rd World Congress on Hepatitis and Liver Diseases, October 10-12, 2016 Dubai, UAE; International Conference on Pancreatic Disorders and Treatment, October 17-19, 2016 Chicago, USA; European Gastroenterology Conference, October 24-25, 2016 Valencia, Spain; International Conference on Endoscopy, November 17-18, 2016 Atlanta, USA; International Conference on Digestive Diseases, December 08-09, 2016 Dubai, UAE; Digestive Disease Week, May 21-24, 2016 San Diego, USA; International Course on Gastroenterology Trujillo 2016, June 30, 2016 - July 2, 2016 Peru; Pan American Digestive Disease Week, September 10-13, 2016 Columbia; 24th Annual Meeting of the Croatian Society of Gastroenterology, September 15-18, 2016 Croatia; XXII Russian Gastroenterological Week, October 03-05, 2016, Moscow, Russia; XXV Peruvian Congress of Digestive Diseases, October 05-08, 2016 Lima, Peru; Asian Pacific Digestive Week, November 02-05, 2016 Kobe, Japan; Japan Digestive Disease Week, November 03-06, 2016 Kobe, Japan; Seoul International Digestive Disease Symposium, November 24-25, 2016 South Korea; 57th Annual Conference of Indian Society of Gastroenterology, December 15-18, 2016 New Delhi, India; American Association for the Study of Liver DiseasesAmerican Hepato-Pancreato-Biliary AssociationAmerican Liver FoundationEuropean Association for the Study of the LiverAsian Pacific Association for the Study of the LiverInternational Association for the Study of the LiverBritish Association for the Study of the LiverCanadian Association for the Study of the LiverCanadian Liver FoundationChildren's Liver Disease FoundationEuroliver FoundationHepatitis B FoundationHepatitis Foundation InternationalInternational Liver Transplantation SocietyInternational Hepato Pancreato Biliary Association

Track 3: Hepatitis B

Hepatitis B is a liver infection caused by the Hepatitis B virus (HBV). HBV is transmitted through activities that involve percutaneous or mucosal contact with infectious blood or body fluids. HBV can survive outside the body at least 7 days and still be capable of causing infection. The best way to prevent hepatitis B is by getting the hepatitis B vaccine. The pathogenesis and clinical manifestations of hepatitis B are due to the interaction of the virus and the host immune system, which lead to liver injury and potentially cirrhosis and hepatocellular carcinoma. Patients can have either an acute symptomatic disease or an asymptomatic disease.

Related Hepatitis Conferences | Liver Conferences | Conference Series LLC: 2nd International Conference on Hepatology, May 09-11, 2016 Chicago, USA; 6th Global Gastroenterologists Meeting, August 11-12, 2016 Birmingham, UK; 7th Gastroenterology and Gastroenterologists Annual Meeting, September 12-14, 2016 Atlanta, USA; 8th International Conference on Clinical Gastroenterology & Hepatology September 29-October 1, 2016 Toronto, Canada; 3rd World Congress on Hepatitis and Liver Diseases, October 10-12, 2016 Dubai, UAE; International Conference on Pancreatic Disorders and Treatment, October 17-19, 2016 Chicago, USA; European Gastroenterology Conference, October 24-25, 2016 Valencia, Spain; International Conference on Endoscopy, November 17-18, 2016 Atlanta, USA; International Conference on Digestive Diseases, December 08-09, 2016 Dubai, UAE; Digestive Disease Week, May 21-24, 2016 San Diego, USA; International Course on Gastroenterology Trujillo 2016, June 30, 2016 - July 2, 2016 Peru; Pan American Digestive Disease Week, September 10-13, 2016 Columbia; 24th Annual Meeting of the Croatian Society of Gastroenterology, September 15-18, 2016 Croatia; XXII Russian Gastroenterological Week, October 03-05, 2016, Moscow, Russia; XXV Peruvian Congress of Digestive Diseases, October 05-08, 2016 Lima, Peru; Asian Pacific Digestive Week, November 02-05, 2016 Kobe, Japan; Japan Digestive Disease Week, November 03-06, 2016 Kobe, Japan; Seoul International Digestive Disease Symposium, November 24-25, 2016 South Korea; 57th Annual Conference of Indian Society of Gastroenterology, December 15-18, 2016 New Delhi, India; American Association for the Study of Liver DiseasesAmerican Hepato-Pancreato-Biliary AssociationAmerican Liver FoundationEuropean Association for the Study of the LiverAsian Pacific Association for the Study of the LiverInternational Association for the Study of the LiverBritish Association for the Study of the LiverCanadian Association for the Study of the LiverCanadian Liver FoundationChildren's Liver Disease FoundationEuroliver FoundationHepatitis B FoundationHepatitis Foundation InternationalInternational Liver Transplantation SocietyInternational Hepato Pancreato Biliary Association

Track 4: Hepatitis C

Hepatitis C is a devastating viral disease that generally progresses slowly, meaning patients often remain asymptomatic and unaware they are infected until very serious and often expensive complications emerge as a result of damage to the liver. It is estimated that about half of those infected are not aware that they carry the virus. The recent remarkable advances in treating hepatitis C built on incremental improvements achieved over the previous two decades to transform hepatitis C from a chronic, fatal disease, to an infection that with new and forthcoming treatments, can be potentially cured.

Related Hepatitis Conferences | Liver Conferences | Conference Series LLC: 2nd International Conference on Hepatology, May 09-11, 2016 Chicago, USA; 6th Global Gastroenterologists Meeting, August 11-12, 2016 Birmingham, UK; 7th Gastroenterology and Gastroenterologists Annual Meeting, September 12-14, 2016 Atlanta, USA; 8th International Conference on Clinical Gastroenterology & Hepatology September 29-October 1, 2016 Toronto, Canada; 3rd World Congress on Hepatitis and Liver Diseases, October 10-12, 2016 Dubai, UAE; International Conference on Pancreatic Disorders and Treatment, October 17-19, 2016 Chicago, USA; European Gastroenterology Conference, October 24-25, 2016 Valencia, Spain; International Conference on Endoscopy, November 17-18, 2016 Atlanta, USA; International Conference on Digestive Diseases, December 08-09, 2016 Dubai, UAE; Digestive Disease Week, May 21-24, 2016 San Diego, USA; International Course on Gastroenterology Trujillo 2016, June 30, 2016 - July 2, 2016 Peru; Pan American Digestive Disease Week, September 10-13, 2016 Columbia; 24th Annual Meeting of the Croatian Society of Gastroenterology, September 15-18, 2016 Croatia; XXII Russian Gastroenterological Week, October 03-05, 2016, Moscow, Russia; XXV Peruvian Congress of Digestive Diseases, October 05-08, 2016 Lima, Peru; Asian Pacific Digestive Week, November 02-05, 2016 Kobe, Japan; Japan Digestive Disease Week, November 03-06, 2016 Kobe, Japan; Seoul International Digestive Disease Symposium, November 24-25, 2016 South Korea; 57th Annual Conference of Indian Society of Gastroenterology, December 15-18, 2016 New Delhi, India; American Association for the Study of Liver DiseasesAmerican Hepato-Pancreato-Biliary AssociationAmerican Liver FoundationEuropean Association for the Study of the LiverAsian Pacific Association for the Study of the LiverInternational Association for the Study of the LiverBritish Association for the Study of the LiverCanadian Association for the Study of the LiverCanadian Liver FoundationChildren's Liver Disease FoundationEuroliver FoundationHepatitis B FoundationHepatitis Foundation InternationalInternational Liver Transplantation SocietyInternational Hepato Pancreato Biliary Association

Track 5: Hepatitis Vaccination

The best way to prevent hepatitis is by getting the hepatitis vaccines. Vaccination is safe and effective and it is recommended for all. Efforts to develop a hepatitis C vaccine started more than 20 years ago, when the hepatitis C virus was identified. The hepatitis C virus is more variable than are the viruses that cause hepatitis A and hepatitis B. Hepatitis C virus occurs in at least six genetically distinct forms with 50 subtypes. A global vaccine would have to protect against all these variants of the virus.

Related Hepatitis Conferences | Liver Conferences | Conference Series LLC: 2nd International Conference on Hepatology, May 09-11, 2016 Chicago, USA; 6th Global Gastroenterologists Meeting, August 11-12, 2016 Birmingham, UK; 7th Gastroenterology and Gastroenterologists Annual Meeting, September 12-14, 2016 Atlanta, USA; 8th International Conference on Clinical Gastroenterology & Hepatology September 29-October 1, 2016 Toronto, Canada; 3rd World Congress on Hepatitis and Liver Diseases, October 10-12, 2016 Dubai, UAE; International Conference on Pancreatic Disorders and Treatment, October 17-19, 2016 Chicago, USA; European Gastroenterology Conference, October 24-25, 2016 Valencia, Spain; International Conference on Endoscopy, November 17-18, 2016 Atlanta, USA; International Conference on Digestive Diseases, December 08-09, 2016 Dubai, UAE; Digestive Disease Week, May 21-24, 2016 San Diego, USA; International Course on Gastroenterology Trujillo 2016, June 30, 2016 - July 2, 2016 Peru; Pan American Digestive Disease Week, September 10-13, 2016 Columbia; 24th Annual Meeting of the Croatian Society of Gastroenterology, September 15-18, 2016 Croatia; XXII Russian Gastroenterological Week, October 03-05, 2016, Moscow, Russia; XXV Peruvian Congress of Digestive Diseases, October 05-08, 2016 Lima, Peru; Asian Pacific Digestive Week, November 02-05, 2016 Kobe, Japan; Japan Digestive Disease Week, November 03-06, 2016 Kobe, Japan; Seoul International Digestive Disease Symposium, November 24-25, 2016 South Korea; 57th Annual Conference of Indian Society of Gastroenterology, December 15-18, 2016 New Delhi, India; American Association for the Study of Liver DiseasesAmerican Hepato-Pancreato-Biliary AssociationAmerican Liver FoundationEuropean Association for the Study of the LiverAsian Pacific Association for the Study of the LiverInternational Association for the Study of the LiverBritish Association for the Study of the LiverCanadian Association for the Study of the LiverCanadian Liver FoundationChildren's Liver Disease FoundationEuroliver FoundationHepatitis B FoundationHepatitis Foundation InternationalInternational Liver Transplantation SocietyInternational Hepato Pancreato Biliary Association

Track 6: Liver Diseases Diagnostics

Screening for Liver diseases has been advocated with the intention of intervening to halt its progression. Abnormal liver tests are those that measure synthesis of proteins made by the liver (albumin, clotting factors) or the liver's capacity to metabolize drugs. The impact of diagnosis of hepatitis C virus on quality of life is worse in patients aware of their viral status compared with individuals unaware of their viral status.

Related Hepatitis Conferences | Liver Conferences | Conference Series LLC: 2nd International Conference on Hepatology, May 09-11, 2016 Chicago, USA; 6th Global Gastroenterologists Meeting, August 11-12, 2016 Birmingham, UK; 7th Gastroenterology and Gastroenterologists Annual Meeting, September 12-14, 2016 Atlanta, USA; 8th International Conference on Clinical Gastroenterology & Hepatology September 29-October 1, 2016 Toronto, Canada; 3rd World Congress on Hepatitis and Liver Diseases, October 10-12, 2016 Dubai, UAE; International Conference on Pancreatic Disorders and Treatment, October 17-19, 2016 Chicago, USA; European Gastroenterology Conference, October 24-25, 2016 Valencia, Spain; International Conference on Endoscopy, November 17-18, 2016 Atlanta, USA; International Conference on Digestive Diseases, December 08-09, 2016 Dubai, UAE; Digestive Disease Week, May 21-24, 2016 San Diego, USA; International Course on Gastroenterology Trujillo 2016, June 30, 2016 - July 2, 2016 Peru; Pan American Digestive Disease Week, September 10-13, 2016 Columbia; 24th Annual Meeting of the Croatian Society of Gastroenterology, September 15-18, 2016 Croatia; XXII Russian Gastroenterological Week, October 03-05, 2016, Moscow, Russia; XXV Peruvian Congress of Digestive Diseases, October 05-08, 2016 Lima, Peru; Asian Pacific Digestive Week, November 02-05, 2016 Kobe, Japan; Japan Digestive Disease Week, November 03-06, 2016 Kobe, Japan; Seoul International Digestive Disease Symposium, November 24-25, 2016 South Korea; 57th Annual Conference of Indian Society of Gastroenterology, December 15-18, 2016 New Delhi, India; American Association for the Study of Liver DiseasesAmerican Hepato-Pancreato-Biliary AssociationAmerican Liver FoundationEuropean Association for the Study of the LiverAsian Pacific Association for the Study of the LiverInternational Association for the Study of the LiverBritish Association for the Study of the LiverCanadian Association for the Study of the LiverCanadian Liver FoundationChildren's Liver Disease FoundationEuroliver FoundationHepatitis B FoundationHepatitis Foundation InternationalInternational Liver Transplantation SocietyInternational Hepato Pancreato Biliary Association

Track 7: Liver Diseases

Liver diseases are caused by metabolic, genetic drug induced and due to autoimmune diseases. Hepatic coma also known as Hepatic encephalopathy is a metabolic abnormality caused by accumulation of toxic substances in the bloodstream that are normally removed by the liver. Haemochromatosis is a genetic disorder caused by accumulation of iron in the liver. Non-alcoholic fatty liver disease is a drug induced liver disease caused by accumulation of extra fat in liver cells that is not caused by alcohol, whereas Alcoholic liver disease is due to overconsumption of alcohol. Primary biliary cirrhosis is an autoimmune disease of the liver in which the bile ducts in liver are slowly destroyed.

Related Hepatitis Conferences | Liver Conferences | Conference Series LLC: 2nd International Conference on Hepatology, May 09-11, 2016 Chicago, USA; 6th Global Gastroenterologists Meeting, August 11-12, 2016 Birmingham, UK; 7th Gastroenterology and Gastroenterologists Annual Meeting, September 12-14, 2016 Atlanta, USA; 8th International Conference on Clinical Gastroenterology & Hepatology September 29-October 1, 2016 Toronto, Canada; 3rd World Congress on Hepatitis and Liver Diseases, October 10-12, 2016 Dubai, UAE; International Conference on Pancreatic Disorders and Treatment, October 17-19, 2016 Chicago, USA; European Gastroenterology Conference, October 24-25, 2016 Valencia, Spain; International Conference on Endoscopy, November 17-18, 2016 Atlanta, USA; International Conference on Digestive Diseases, December 08-09, 2016 Dubai, UAE; Digestive Disease Week, May 21-24, 2016 San Diego, USA; International Course on Gastroenterology Trujillo 2016, June 30, 2016 - July 2, 2016 Peru; Pan American Digestive Disease Week, September 10-13, 2016 Columbia; 24th Annual Meeting of the Croatian Society of Gastroenterology, September 15-18, 2016 Croatia; XXII Russian Gastroenterological Week, October 03-05, 2016, Moscow, Russia; XXV Peruvian Congress of Digestive Diseases, October 05-08, 2016 Lima, Peru; Asian Pacific Digestive Week, November 02-05, 2016 Kobe, Japan; Japan Digestive Disease Week, November 03-06, 2016 Kobe, Japan; Seoul International Digestive Disease Symposium, November 24-25, 2016 South Korea; 57th Annual Conference of Indian Society of Gastroenterology, December 15-18, 2016 New Delhi, India; American Association for the Study of Liver DiseasesAmerican Hepato-Pancreato-Biliary AssociationAmerican Liver FoundationEuropean Association for the Study of the LiverAsian Pacific Association for the Study of the LiverInternational Association for the Study of the LiverBritish Association for the Study of the LiverCanadian Association for the Study of the LiverCanadian Liver FoundationChildren's Liver Disease FoundationEuroliver FoundationHepatitis B FoundationHepatitis Foundation InternationalInternational Liver Transplantation SocietyInternational Hepato Pancreato Biliary Association

Track 8: Liver Cancer

Hepatocellular carcinoma is the most common form of liver cancer in adults. It begins in the hepatocytes, the main type of liver cell. The production of cancer cells in the Liver is called hepato-carcinogenesis. Research is going on to develop drugs that builds liver cancer immunity and also identifying and understanding cancer stem cells and their properties to develop effective anti-cancer therapies.

Related Hepatitis Conferences | Liver Conferences | Conference Series LLC: 2nd International Conference on Hepatology, May 09-11, 2016 Chicago, USA; 6th Global Gastroenterologists Meeting, August 11-12, 2016 Birmingham, UK; 7th Gastroenterology and Gastroenterologists Annual Meeting, September 12-14, 2016 Atlanta, USA; 8th International Conference on Clinical Gastroenterology & Hepatology September 29-October 1, 2016 Toronto, Canada; 3rd World Congress on Hepatitis and Liver Diseases, October 10-12, 2016 Dubai, UAE; International Conference on Pancreatic Disorders and Treatment, October 17-19, 2016 Chicago, USA; European Gastroenterology Conference, October 24-25, 2016 Valencia, Spain; International Conference on Endoscopy, November 17-18, 2016 Atlanta, USA; International Conference on Digestive Diseases, December 08-09, 2016 Dubai, UAE; Digestive Disease Week, May 21-24, 2016 San Diego, USA; International Course on Gastroenterology Trujillo 2016, June 30, 2016 - July 2, 2016 Peru; Pan American Digestive Disease Week, September 10-13, 2016 Columbia; 24th Annual Meeting of the Croatian Society of Gastroenterology, September 15-18, 2016 Croatia; XXII Russian Gastroenterological Week, October 03-05, 2016, Moscow, Russia; XXV Peruvian Congress of Digestive Diseases, October 05-08, 2016 Lima, Peru; Asian Pacific Digestive Week, November 02-05, 2016 Kobe, Japan; Japan Digestive Disease Week, November 03-06, 2016 Kobe, Japan; Seoul International Digestive Disease Symposium, November 24-25, 2016 South Korea; 57th Annual Conference of Indian Society of Gastroenterology, December 15-18, 2016 New Delhi, India; American Association for the Study of Liver DiseasesAmerican Hepato-Pancreato-Biliary AssociationAmerican Liver FoundationEuropean Association for the Study of the LiverAsian Pacific Association for the Study of the LiverInternational Association for the Study of the LiverBritish Association for the Study of the LiverCanadian Association for the Study of the LiverCanadian Liver FoundationChildren's Liver Disease FoundationEuroliver FoundationHepatitis B FoundationHepatitis Foundation InternationalInternational Liver Transplantation SocietyInternational Hepato Pancreato Biliary Association

Track 9: Pregnancy and Liver Diseases

Several disorders contribute to liver disease in pregnancy such as acute fatty liver of pregnancy (AFLP) and intrahepatic cholestasis of pregnancy (IHCP), hyperemesis gravidarum and hemolysis and elevated liver enzymes and low platelets (HELLP) syndrome. Liver disease such as acute viral hepatitis can occur in pregnancy and pregnancy may occur in a patient with underlying chronic liver disease including patients with cirrhosis and portal hypertension, and patients who have undergone liver transplantation.

Related Hepatitis Conferences | Liver Conferences | Conference Series LLC: 2nd International Conference on Hepatology, May 09-11, 2016 Chicago, USA; 6th Global Gastroenterologists Meeting, August 11-12, 2016 Birmingham, UK; 7th Gastroenterology and Gastroenterologists Annual Meeting, September 12-14, 2016 Atlanta, USA; 8th International Conference on Clinical Gastroenterology & Hepatology September 29-October 1, 2016 Toronto, Canada; 3rd World Congress on Hepatitis and Liver Diseases, October 10-12, 2016 Dubai, UAE; International Conference on Pancreatic Disorders and Treatment, October 17-19, 2016 Chicago, USA; European Gastroenterology Conference, October 24-25, 2016 Valencia, Spain; International Conference on Endoscopy, November 17-18, 2016 Atlanta, USA; International Conference on Digestive Diseases, December 08-09, 2016 Dubai, UAE; Digestive Disease Week, May 21-24, 2016 San Diego, USA; International Course on Gastroenterology Trujillo 2016, June 30, 2016 - July 2, 2016 Peru; Pan American Digestive Disease Week, September 10-13, 2016 Columbia; 24th Annual Meeting of the Croatian Society of Gastroenterology, September 15-18, 2016 Croatia; XXII Russian Gastroenterological Week, October 03-05, 2016, Moscow, Russia; XXV Peruvian Congress of Digestive Diseases, October 05-08, 2016 Lima, Peru; Asian Pacific Digestive Week, November 02-05, 2016 Kobe, Japan; Japan Digestive Disease Week, November 03-06, 2016 Kobe, Japan; Seoul International Digestive Disease Symposium, November 24-25, 2016 South Korea; 57th Annual Conference of Indian Society of Gastroenterology, December 15-18, 2016 New Delhi, India; American Association for the Study of Liver DiseasesAmerican Hepato-Pancreato-Biliary AssociationAmerican Liver FoundationEuropean Association for the Study of the LiverAsian Pacific Association for the Study of the LiverInternational Association for the Study of the LiverBritish Association for the Study of the LiverCanadian Association for the Study of the LiverCanadian Liver FoundationChildren's Liver Disease FoundationEuroliver FoundationHepatitis B FoundationHepatitis Foundation InternationalInternational Liver Transplantation SocietyInternational Hepato Pancreato Biliary Association

Track 10: Non-Viral Hepatitis

Non-viral hepatitis is an inflammation of the liver caused by toxins, drugs, or other harmful chemicals that destroy cells in the liver (Hepatocytes). Acute hepatitis damages hepatocytes, make up 70-85% of the total mass of the liver. The disease is a growing problem due to the increasing number of dietary supplements with liver side effects. If hepatitis leads to liver failure, a liver transplant is the only treatment option that can improve survival

Related Hepatitis Conferences | Liver Conferences | Conference Series LLC: 2nd International Conference on Hepatology, May 09-11, 2016 Chicago, USA; 6th Global Gastroenterologists Meeting, August 11-12, 2016 Birmingham, UK; 7th Gastroenterology and Gastroenterologists Annual Meeting, September 12-14, 2016 Atlanta, USA; 8th International Conference on Clinical Gastroenterology & Hepatology September 29-October 1, 2016 Toronto, Canada; 3rd World Congress on Hepatitis and Liver Diseases, October 10-12, 2016 Dubai, UAE; International Conference on Pancreatic Disorders and Treatment, October 17-19, 2016 Chicago, USA; European Gastroenterology Conference, October 24-25, 2016 Valencia, Spain; International Conference on Endoscopy, November 17-18, 2016 Atlanta, USA; International Conference on Digestive Diseases, December 08-09, 2016 Dubai, UAE; Digestive Disease Week, May 21-24, 2016 San Diego, USA; International Course on Gastroenterology Trujillo 2016, June 30, 2016 - July 2, 2016 Peru; Pan American Digestive Disease Week, September 10-13, 2016 Columbia; 24th Annual Meeting of the Croatian Society of Gastroenterology, September 15-18, 2016 Croatia; XXII Russian Gastroenterological Week, October 03-05, 2016, Moscow, Russia; XXV Peruvian Congress of Digestive Diseases, October 05-08, 2016 Lima, Peru; Asian Pacific Digestive Week, November 02-05, 2016 Kobe, Japan; Japan Digestive Disease Week, November 03-06, 2016 Kobe, Japan; Seoul International Digestive Disease Symposium, November 24-25, 2016 South Korea; 57th Annual Conference of Indian Society of Gastroenterology, December 15-18, 2016 New Delhi, India; American Association for the Study of Liver DiseasesAmerican Hepato-Pancreato-Biliary AssociationAmerican Liver FoundationEuropean Association for the Study of the LiverAsian Pacific Association for the Study of the LiverInternational Association for the Study of the LiverBritish Association for the Study of the LiverCanadian Association for the Study of the LiverCanadian Liver FoundationChildren's Liver Disease FoundationEuroliver FoundationHepatitis B FoundationHepatitis Foundation InternationalInternational Liver Transplantation SocietyInternational Hepato Pancreato Biliary Association

Track 11: Drug Discovery for Treatment of Hepatitis

In recent years, tremendous research advances are transforming treatment of Hepatitis. More than 90% of patients with the most common form of the disease can expect to be cured in as little as 8 weeks with newly approved antiviral therapies. More new medicines are on the way. Most of this progress has occurred in just the last three years with newer and more effective therapies transforming the trajectory of the disease for many patients. The scientific advances made in recent years by biopharmaceutical researchers as they combat the hepatitis C virus have already begun to have a tangible impact on thousands of patients.

Related Hepatitis Conferences | Liver Conferences | Conference Series LLC: 2nd International Conference on Hepatology, May 09-11, 2016 Chicago, USA; 6th Global Gastroenterologists Meeting, August 11-12, 2016 Birmingham, UK; 7th Gastroenterology and Gastroenterologists Annual Meeting, September 12-14, 2016 Atlanta, USA; 8th International Conference on Clinical Gastroenterology & Hepatology September 29-October 1, 2016 Toronto, Canada; 3rd World Congress on Hepatitis and Liver Diseases, October 10-12, 2016 Dubai, UAE; International Conference on Pancreatic Disorders and Treatment, October 17-19, 2016 Chicago, USA; European Gastroenterology Conference, October 24-25, 2016 Valencia, Spain; International Conference on Endoscopy, November 17-18, 2016 Atlanta, USA; International Conference on Digestive Diseases, December 08-09, 2016 Dubai, UAE; Digestive Disease Week, May 21-24, 2016 San Diego, USA; International Course on Gastroenterology Trujillo 2016, June 30, 2016 - July 2, 2016 Peru; Pan American Digestive Disease Week, September 10-13, 2016 Columbia; 24th Annual Meeting of the Croatian Society of Gastroenterology, September 15-18, 2016 Croatia; XXII Russian Gastroenterological Week, October 03-05, 2016, Moscow, Russia; XXV Peruvian Congress of Digestive Diseases, October 05-08, 2016 Lima, Peru; Asian Pacific Digestive Week, November 02-05, 2016 Kobe, Japan; Japan Digestive Disease Week, November 03-06, 2016 Kobe, Japan; Seoul International Digestive Disease Symposium, November 24-25, 2016 South Korea; 57th Annual Conference of Indian Society of Gastroenterology, December 15-18, 2016 New Delhi, India; American Association for the Study of Liver DiseasesAmerican Hepato-Pancreato-Biliary AssociationAmerican Liver FoundationEuropean Association for the Study of the LiverAsian Pacific Association for the Study of the LiverInternational Association for the Study of the LiverBritish Association for the Study of the LiverCanadian Association for the Study of the LiverCanadian Liver FoundationChildren's Liver Disease FoundationEuroliver FoundationHepatitis B FoundationHepatitis Foundation InternationalInternational Liver Transplantation SocietyInternational Hepato Pancreato Biliary Association

Track 12: Clinical Liver Transplantation

Liver transplantation is the only treatment possible option for end-stage liver disease and acute liver failureResearch is going on development of artificial liver support, a technology based on artificial materials for partial replacement of liver function. Liver surgery comprises various operations of the liver for different disorders. The most common operation performed on the liver is a resection (removal of a portion of the liver).

Related Hepatitis Conferences | Liver Conferences | Conference Series LLC: 2nd International Conference on Hepatology, May 09-11, 2016 Chicago, USA; 6th Global Gastroenterologists Meeting, August 11-12, 2016 Birmingham, UK; 7th Gastroenterology and Gastroenterologists Annual Meeting, September 12-14, 2016 Atlanta, USA; 8th International Conference on Clinical Gastroenterology & Hepatology September 29-October 1, 2016 Toronto, Canada; 3rd World Congress on Hepatitis and Liver Diseases, October 10-12, 2016 Dubai, UAE; International Conference on Pancreatic Disorders and Treatment, October 17-19, 2016 Chicago, USA; European Gastroenterology Conference, October 24-25, 2016 Valencia, Spain; International Conference on Endoscopy, November 17-18, 2016 Atlanta, USA; International Conference on Digestive Diseases, December 08-09, 2016 Dubai, UAE; Digestive Disease Week, May 21-24, 2016 San Diego, USA; International Course on Gastroenterology Trujillo 2016, June 30, 2016 - July 2, 2016 Peru; Pan American Digestive Disease Week, September 10-13, 2016 Columbia; 24th Annual Meeting of the Croatian Society of Gastroenterology, September 15-18, 2016 Croatia; XXII Russian Gastroenterological Week, October 03-05, 2016, Moscow, Russia; XXV Peruvian Congress of Digestive Diseases, October 05-08, 2016 Lima, Peru; Asian Pacific Digestive Week, November 02-05, 2016 Kobe, Japan; Japan Digestive Disease Week, November 03-06, 2016 Kobe, Japan; Seoul International Digestive Disease Symposium, November 24-25, 2016 South Korea; 57th Annual Conference of Indian Society of Gastroenterology, December 15-18, 2016 New Delhi, India; American Association for the Study of Liver DiseasesAmerican Hepato-Pancreato-Biliary AssociationAmerican Liver FoundationEuropean Association for the Study of the LiverAsian Pacific Association for the Study of the LiverInternational Association for the Study of the LiverBritish Association for the Study of the LiverCanadian Association for the Study of the LiverCanadian Liver FoundationChildren's Liver Disease FoundationEuroliver FoundationHepatitis B FoundationHepatitis Foundation InternationalInternational Liver Transplantation SocietyInternational Hepato Pancreato Biliary Association

 

 

Conference Series LLC will be honored to invite you to the 3rd World Congress on Hepatitis and Liver diseases (Hepatitis 2016) to be held in beautiful city, Dubai, UAE during October 10-12, 2016. The conference highlights the theme “Treatment and Management strategies to eradicate Hepatitis and Liver diseases”. The event will serve as a catalyst for the advancement of research in the field of Hepatitis and Liver diseases by connecting scientists within and across the globe, creating a environment conducive to information exchange, generation of ideas and acceleration of applications that benefit society.

The event offers a best platform with its well organized scientific program to the audience which includes symposiums, workshops, keynote lectures, plenary talks, panel discussions and poster sessions on latest  research and technological developments in the arena as well as therapeutic aspects. The conference invites Hepatologists, Gastroenterologists, Internists, Physicians, Microbiologists, Virologists, Pathologists, Oncologists, Surgeons, Toxicologists, Researchers, Students, Business delegates and Young researchers across the globe.

Conference Series LLC organizes 300+ International Conferences Every Year across USA, Europe & Asia with support from 1000 more scientific Societies and publishes 400+ Open Access Journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

The liver supports almost every organ in the body and is vital for survival. Because of its strategic location and multidimensional functions, the liver is also prone to many diseases. Hepatitis is a common condition of inflammation of the liver. The most usual cause of this is viral, and the most common of these infections are hepatitis A, B, C, D, and E. Infection with hepatitis B virus or hepatitis C virus is the main cause of liver cancer. Other disorders caused by excessive alcohol consumption are grouped under alcoholic liver diseases and these include alcoholic hepatitis, fatty liver, and cirrhosis. Liver damage can also be caused by drugs, particularly paracetomol and drugs used to treat cancer.

Conference Opportunities

For Researchers and Faculty Members:

Speaker Presentations
Poster Display
Symposium hosting (4-5 member team)
Workshop organizing

For Universities, Associations & Societies:

Association Partnering
Collaboration proposals
Academic Partnering
Group Participation

For Students and Research Scholars:

Poster Competition (Winner will get Best Poster Award)
Young Researcher Forum (YRF Award to the best presenter)
Student Attendee
Group registrations

For Business Delegates:

Speaker Presentations
Symposium hosting
Book Launch event
Networking opportunities
Audience participation

For Product Manufacturers:

Exhibitor and Vendor booths
Sponsorships opportunities
Product launch
Workshop organizing
Scientific Partnering
Marketing and Networking with clients

 

Pregnancy and Liver Diseases

 

Liver diseases are caused by metabolic, genetic drug induced and due to autoimmune diseases. Hepatic coma also known as Hepatic encephalopathy is a metabolic abnormality caused by accumulation of toxic substances in the bloodstream that are normally removed by the liver. Haemochromatosis is a genetic disorder caused by accumulation of iron in the liver. Non-alcoholic fatty liver disease is a drug induced liver disease caused by accumulation of extra fat in liver cells that is not caused by alcohol, whereas Alcoholic liver disease is due to overconsumption of alcohol. Primary biliary cirrhosis is an autoimmune disease of the liver in which the bile ducts in liver are slowly destroyed. - See more at: http://hepatitis.omicsgroup.com/call-for-abstracts.php#sthash.jZAbmZHM.dpu

Hepatitis is an inflammatory disorder of the liver, caused by viruses, drugs, and toxins. Viral hepatitis is one of the major global health care problems and kills around 1.5 million people worldwide every year. The prevalence of viral hepatitis varies from region to region, but is generally higher in Middle Eastern countries. The three major viruses that affect the liver, hepatitis A, B, and C (HAV, HBV, HCV). HAV is the most common cause of acute hepatitis in children in the Middle East. 10,000,000 new cases of Hepatitis A reported globally every year. The prevalence of HAV in Iran is very high. The seroprevalence of HAV was 85% in the capital Tehran, 96% in Hormozgan in southern Iran, and 99% in Golestan in the north of the country. In most areas of Iran, more than 90% of people aged 33 years or older are seropositive for anti-HAV antibody. The rate in the Middle East varies from 0.6% in Iraq to more than 8% in Sudan. The rate is 5.1% in Yemen, 3.6% in Algeria, and 3.5% in Kuwait and the occupied Palestinian territory.

More than 2 000 million people alive today have been infected with HBV at some time in their lives. Of these, about 350 million remain infected chronically and become carriers of the virus. Three quarters of the world’s population live in areas where there are high levels of infection. Every year there are over 4 million acute clinical cases of HBV, and about 25% of carriers, 1 million people a year, die from chronic active hepatitis, cirrhosis or primary liver cancer. High endemicity areas include sub-Saharan Africa, the Middle East, the central Asian Republics, and some countries in eastern Europe. In these areas, about 70 to 90% of the population becomes HBV-infected before the age of 40, and 8 to 20% of people are HBV carriers. In countries such as China, Senegal, and Thailand, infection rates are very high in infants, and continue through early childhood. At that stage the prevalence of HBsAg in serum may exceed 25%. HBV is well studied in Saudi Arabia where the prevalence in the general population is 4.25%. The genotype of the virus D predominates in the Middle East.

The highest prevalence (17.5%) of HCV in the world was reported in Egypt. The pooled prevalence of HCV in haemodialysis patients is 16% in Iran, 56% in Saudi Arabia, 52% in Syria, and 34% in Sudan. Patients infected with HBV and HCV have an increased risk of developing various liver diseases, including cirrhosis and hepatocellular carcinoma: 15–40% of patients infected with HBV are at risk of developing cirrhosis and hepatocellular carcinoma if left untreated. Roughly 1.5 million people in Iran are living with HBV and are at risk of developing cirrhosis and hepatocellular carcinoma. The high prevalence of HBV and HCV infections in some countries in the Middle East is alarming and is a challenge for health-care policy makers. Raising public awareness of viral hepatitis risk factors is an important step. Hepatitis screening in selected risk groups need to be implemented to reduce the future burden of viral infection.

Scope:

Hepatitis 2016 Conference is to bring top experts together and delegates for an in-depth discussion on Hepatitis and Liver diseases. To create awareness for both rural and urban population about liver disease it should be diagnosed at early stages. The importance of this conference is to update, clinically relevant audience regarding the evidence supporting current clinical practices in hepatocellular carcinoma and hepatitis medicine. The information presented is intended to enhance clinical competence in the diagnosis and treatment of hepatitis and liver disease. Hepatitis 2016 describes the health risks and effects associated with the Human life. This Conference will address scientific research to take new steps in therapeutics & techniques involved.  The conference we are conducting on liver disease is to get awareness in the people. It will explain how to protect liver from hepatitis and other viral disease.

Hepatitis 2016 conference aims at gathering the audience from all the major parts of the world with a goal to enhance the scientific knowledge by exploring the latest advancements in the related conference field area. The conference will include explicit keynote and plenary sessions delivered by the distinguished researchers, scientists and honorary lecturers working in the field of hepatology. Hepatitis 2016 will encourage the participation of the eminent professors, researchers and students in all areas of hepatology and will provide an international forum for the dissemination of original research results, new ideas and practical development experiences concentrating on the scientific development.

Medical Universities in UAE:

  • Gulf Medical University
  • Dubai Medical College
  • RAK Medical & Health Sciences University
  • United Arab Emirates University
  • Dubai Medical College for Girls
  • University of Sharjah
  • King Saud University
  • University of Dammam
  • King Faisal University
  • Al Jouf University
  • Taibah University
  • Al-Majmaah University
  • Tabuk University
  • Taif University
  • King Khalid University
  • King AbdulazizUniversity
  • Batterjee Medical College for Science & Technology
  • Salman Bin Abdlaziz University

Pharmaceutical Companies in Dubai:

  • MPC Healthcare
  • Alain Pharmacy New
  • Alain Pharmacy Euro Health
  • Al Hayat Pharmaceuticals
  • Emirates Biotech Pharmaceutical Factory
  • AstraZeneca - Gulf
  • Lunatus
  • Pfizer UAE
  • Merck UAE
  • Gulf Pharmaceutical Industry-Julphar (JULPHAR)
  • Hikma Pharmaceuticals PLC
  • Elis Pharmaceuticals Limited
  • Sanofi Aventis UAE
  • Ranbaxy Laboratories Limited
  • GlaxoSmithKline
  • Saga Pharmaceuticals
  • Baxter A.G
  • Johnson & Johnson Middle East
  • Novo Nordisk Pharma Gulf
  • Smart Health and Nutrition Ltd.
  • Valeant Pharmaceuticals MEA FZ LLC
  • Amgen
  • Alliance Global
  • Genpharm
  • BioPharma
  • Gulf Inject
  • Global Pharma
  • NeoPharma
  • Medpharma
Hepatitis 2015

 

OMICS International takes a great pride in announcing the commencement of "World Congress on Hepatitis” during July 20-22, 2015 at Hyatt Regency Orlando International Airport, Florida, USA. The conference highlights the theme “Raising global awareness on hepatitis and fighting the stigma surrounding the disease”. It is the annual meeting for the study of Hepatitis.

With the support and contribution of the organizing committee members, we successfully hosted an event at the conference venue. Active participation and generous response were received from the Organizing Committee Members, Editorial Board Members of OMICS Group Journals, Professors, Researchers, Experts and Students from diverse groups who made this conference as one of the most successful and productive event in 2015 from OMICS International. The conference was marked with the attendance of young researchers, business delegates and students who have driven this event into the path of success.  

The conference was initiated with a warm welcome note from Honorable guests and the Keynote forum lead by Dr. Mark A Feitelson, Associate Director, Temple University, USA. The proceedings went through interactive sessions and panel discussions headed by Dr. Trent W Nichols, AMRI, USA, an honorable Moderator for the conference, who contributed a major part for the success of this event. The event offers a best platform with its well organized scientific program to the audience on the topics Hepatitis Care and Cure, Diagnosis & Liver Pathology/ Case Studies, Assessment of Liver Diseases, Liver  cancer and Hepatocellular carcinoma, Advanced Management of Liver diseases, Clinical Liver Transplantation and Liver Surgery, Advancement in new drug discovery for treatment of hepatitis, Advance Technologies for the treatment of hepatitis and Liver diseases, Current research in Hepatology.

The conference witnessed an amalgamation of peerless speakers, who enlightened the crowd with their enviable research knowledge and on various alluring topics related to the field of hepatitis, carried out through various scientific-sessions and plenary lectures:

  • Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells? -Dr. Mark A Feitelson, Temple University, USA
  • The Growing Epidemic in HCC from Hepatitis/NASH Cirrhosis in American Veterans-Dr. Trent W Nichols, AMRI, USA
  • Lower GI Bleeding in Patients with cirrhosis- Dr. Maxwell M Chait, Columbia University, USA
  • Impacts of platelets on the prognosis of patients with hepatocellular carcinoma– Dr. Sen-Yung Hsieh, Chang Gung Memorial Hospital, Taiwan

Also, the conference proceeding was encouraged through the wonderful symposiums by Dr. Andre Jean Remy, Perpignan Hospital, France, on the title ” New tools of screening viral hepatitis in real life: The French model of care and by Dr. Ehab Abd-El-Atty, Menoufia University, Egypt, on the title “HCC risk factors synergism in Egypt and how to prevent?”

A workshop session was done on “The Cirrhosis Micro-environment and Hepato-carcinogenesis” by Dr. Sen-Yung Hsieh, Chang Gung Memorial Hospital, Taiwan.

OMICS International has taken the privilege of felicitating Hepatitis-2015 Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this event. OMICS International, on behalf of the conference exhibitor congratulate the Best Poster awardee for her outstanding performance in the field of Hepatocellular carcinoma and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors. 

We are glad to inform that all accepted abstracts for the conference have been indexed in OMICS Journal of Liver and Journal of Liver Disease and Transplantation as a special issue.

We sincerely thank the Organizing Committee Members, Editorial Board Members of OMICS Journals, Participants, Attendees, Sponsors, Exhibitors, and Media partners for their gracious presence and generous support, without which the conference would not have been possible. With the unique feedback from the conference, OMICS International would like to announce the commencement of the "2nd International Conference on Hepatology” May 9-11, 2016 in Chicago, USA and “3rd World Congress on Hepatitis and Liver Diseases" October 17-19, 2016 in Dubai, UAE.

 

Let us meet again @ 2016 Conferences


Past Reports  Gallery  

Gastro-2015

 

OMICS International hosted International Conference and Exhibition on Gastrointestinal Therapeutics scheduled during August 25-27, 2015 in Valencia, Spain with the theme, “Advanced Therapeutic Options and Treatment Procedures for Gastrointestinal Disorders".

The conference had multiple sessions including Keynote Presentations, Panel Discussions and Poster Sessions. We received active participation from various scientists, researchers, students and leaders from the field of Gastrointestinal Therapeutics who made this event successful.

Various sessions were carried out with enlightening presentations from speakers all around the world focusing on the below mentioned scientific tracks:

·         Inflammatory Bowel Disease Research vs. Treatment/Management
·         Treatment for Functional GI disorders
·         Gastrointestinal Carcinogenesis and Therapeutics
·         Gastrointestinal Bleeding- Treatment and Management
·         Gastrointestinal Therapeutic Endoscopy- Advancements and Challenges
·         Emerging Therapies for Viral Hepatitis and Liver Fibrosis
·         Recent Advancements and Current Research in Gastrointestinal Therapeutics
·         Probiotics as Gastrointestinal Therapeutics
·         Clinical Nutrition in Gastrointestinal Diseases
·         Gastric Bypass Surgery- Types and Treatment
·         Pancreatic Diseases and Treatment
·         Traditional and Herbal Medications
·         Use of NSAID’s and Antibiotic Therapy
·         Gastrointestinal Pharmacotherapy

The conference was initiated with a series of lectures delivered by both Honorable Guests and Members of the Keynote Forum. The list includes:

  • Dr. Debby Laukens, Ghent University, Belgium
  • Dr. Larry I Good, Good Pharmaceutical Development Company, USA
  • Dr. Ahmed Zaki Helaly, Alexandria University, Egypt
  • Dr. Fratila Ovidiu, University of Oradea, Romania

OMICS International thank all the expert presenters and exuberant participants from all around the World which includes various outside experts, University representatives and other eminent researchers who supported the conference by facilitating the discussion forums.

We would like to thank all of our wonderful Speakers, Conference Attendees, Students, Delegates and Guests for making Gastro-2015 a wonderful event!

With the grand success of Gastro-2015, OMICS International takes the immense pleasure to announce the 7th Global Gastroenterologists Meeting to be held during August 11-12, 2016 in Birmingham, UK.

Let us meet again @ Gastro-2016


Past Reports  Gallery  

Gastroenterology-2015

 

With the trail of success of our previous conferences, OMICS International hosted the 4th International Conference on Gastroenterology (Gastroenterology-2015) during July 20-22, 2015 at Hyatt Regency Orlando, Florida. Generous response was received from the Editorial Board Members of OMICS Journals as well as from eminent scientists, talented researchers and young student community. The three day program witnessed thought provoking keynote and plenary presentations from experts in the field of Advances in Gastrointestinal Diseases, Gastrointestinal Oncology, Gastrointestinal Immunology, Advances in Liver Diseases, Gastrointestinal Surgery and Pediatric Urology highlighting the theme “Current Advancements in Gastroenterology".

Gastroenterology-2015 Organizing Committee would like to thank the Moderator of the conference, Dr. Maxwell M. Chait, Columbia University, USA and Dr. Abigail Basson, University of Western Cape, South Africa who contributed meticulously and exuberantly for the smooth functioning of this event.

OMICS International would like to convey a warm gratitude to all the Honorable Guests and Keynote Speakers of Gastroenterology-2015:

  • Maxwell M. Chait, Columbia University, USA
  • Mary Es. Beaver, Texas Centre of Voice and Swallowing, USA
  • Abigail Basson, University of Western cape, South Africa

All the above mentioned Honorable Guests, Keynote Speakers and other speakers gave their fervent and peerless contributions at Gastroenterology-2015. The conference proceedings were carried out through various Scientific-sessions and plenary lectures.

OMICS International congratulates the Best Poster awardees for their outstanding performance and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors. We would like to thank the Poster Competition Judge Pavel Vodicka, Institute of Experimental Medicine, Czech Republic for his valuable time.          

OMICS International also took the privilege of felicitating Gastroenterology-2015, Chair and Co-Chairs whose paramount support escorted the conference to the pinnacle of success.

  • Mary Es. Beaver, Texas Centre of Voice and Swallowing, USA
  • Na Li, The Ohio State University, USA
  • Abigail Basson, University of Western cape, South Africa
  • Joshua Ko, Hong Kong Baptist University, China
  • Nisreene Mahmoud, Cairo University, Egypt
  • Mrinal Pahwa, Sir Ganga Ram Hospital, India

With the enormous feedback from the participants and supporters of Gastroenterology-2015, OMICS International is glad to announce 7th Gastroenterology and Gastroenterologists Annual Meeting during May 16-18, 2016 in San Antonio, USA. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Gastroenterology research.


Past Reports  Proceedings  Gallery  

Gastroenterology-2014

 

The 3rd International Conference on Gastroenterology & Urology hosted by the OMICS Group was successfully held during July 28-30, 2014 in San Francisco, USA. The conference gathered scientists, researchers and leaders from Gastroenterology & Urology societies, government organizations, students who made this conference as one of the most successful event. 

The conference started on July 28 with an opening ceremony in which honorable guest presentations took place on the theme of this Conference "Accelerating New Research and Technologies in Gastroenterology and Urology". Based on this, speaker's discussions included many recommendations. 

Keynote Speakers:

  • Dr. Maxwell Chait, Columbia University College of Physicians and Surgeons, USA
  • Dr. Christos E Constantinou, Stanford University School of Medicine, USA
  • Dr. Amr Amin, UAE University, UAE

All above mentioned keynote speakers gave their energetic and fruitful contributions at 3rd International Conference on Gastroenterology & Urology.  The session chairs/Co chairs have proved their position and contributed a lot for the smooth functioning of the event.

All accepted abstracts have been indexed in the OMICS Group Journal of Gastrointestinal & Digestive system as a special issue. OMICS Group felicitated all the Organizing Committee Members who enthusiastically participated in the conference and made this meeting a huge success.

With the huge response from scientific fraternity, industries, renowned personalities and Editorial Board Members of OMICS Group across the world, we would like to proudly announce “4th International Conference on Gastroenterology & Urology” during July 20-22, 2015 in Florida, USA. We wish to pioneer a way to another outstanding event in the USA.


Past Reports  Gallery  

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date October 10-12, 2016
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Day 1 Day 2 Day 3
Poster Opportunity Available

Media Partners

Conferenceseries Destinations


Mail us at

Drop us an email for Program enquiry.
hepatitis@conferenceseries.net
Sponsors / Exhibiting / Advertising.
hepatitis@conferenceseries.net
General Queries.
hepatitis@conferenceseries.net

View Proceedings of Previous Conferences

Hepatitis 2015
Infectious Diseases 2015
Virology 2015
Authorization Policy

By registering for the conference you grant permission to Conferenceseries LLC to photograph, film or record and use your name, likeness, image, voice and comments and to publish, reproduce, exhibit, distribute, broadcast, edit and/or digitize the resulting images and materials in publications, advertising materials, or in any other form worldwide without compensation. Taking of photographs and/or videotaping during any session is prohibited. Contact us for any queries.